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ABSTRACT
Background
Genetic and biochemical studies have indicated an important role for lipid metabolism in
human longevity. Ashkenazi Jewish centenarians and their offspring have large low-density
lipoprotein (LDL) and high-density lipoprotein (HDL) particles as compared with control
individuals. This profile also coincided with a lower prevalence of disease. Here, we investigate
whether this observation can be confirmed for familial longevity in an outbred European
population and whether it can be extended to sporadic longevity in the general population.
Methods and Findings
NMR-measured lipoprotein profiles were analyzed in 165 families from the Leiden Longevity
Study, consisting of 340 long-lived siblings (females .91 y, males .89 y), 511 of their offspring,
and 243 partners of the offspring. Offspring had larger (21.3 versus 21.1 nm; p ¼ 0.020) and
fewer (1,470 versus 1,561 nmol/l; p ¼ 0.011) LDL particles than their same-aged partners. This
effect was even more prominent in the long-lived siblings (p , 10
 3) and could be pinpointed
to a reduction specifically in the concentration of small LDL particles. No differences were
observed for HDL particle phenotypes. The mean LDL particle sizes in 259 90-y-old singletons
from a population-based study were similar to those in the long-lived siblings and thus
significantly larger than in partners of the offspring, suggesting that the relevance of this
phenotype extends beyond familial longevity. A low concentration of small LDL particles was
associated with better overall health among both long-lived siblings (p ¼ 0.003) and 90-y-old
singletons (p ¼ 0.007).
Conclusions
Our study indicates that LDL particle profiles mark both familial and sporadic human
longevity already in middle age.
The Editors’ Summary of this article follows the references.
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The study of families displaying exceptional longevity may
reveal the biological basis for a healthy ageing process [1,2].
First-degree relatives of centenarians [3] and nonagenarian
siblings [4] have a lifelong mortality advantage as compared
with their birth cohort. These ﬁndings imply that there is a
substantial familial, possibly genetic, component to excep-
tional longevity. Moreover, they indicate that the factors
involved in longevity express their beneﬁcial effect at earlier
ages and confer resistance to multiple common diseases.
Indeed, the offspring of centenarians with a mean age of 71 y
have a decreased prevalence of [5] and mortality from [6]
coronary heart disease, diabetes, and cancer. Studying genetic
and biochemical markers in long-lived individuals and their
offspring may therefore reveal biological mechanisms that
protect against a broad range of common diseases perhaps
secondary to a decreased rate of biological ageing [5].
Human population studies have indicated a signiﬁcant role
for lipid metabolism in the survival to exceptionally high
ages. Variants of a number of genes involved in this pathway,
including APOE [2], APOB [7] and CETP [8], were associated
with human longevity. The most compelling indication for a
role of lipid metabolism came from the study of NMR-
measured subclasses of lipoprotein particles in long-lived
Ashkenazi Jewish families. Offspring of centenarians had
strikingly larger low-density lipoprotein (LDL) and high-
density lipoprotein (HDL) particles than age-matched con-
trols, and even larger particles were observed among the
centenarians themselves [8]. Larger LDL and HDL particles
were further associated with lower prevalence of hyper-
tension, cardiovascular disease, and the metabolic syndrome
in offspring of centenarians and their spouses [8].
To deﬁnitively establish the relevance of lipoprotein
particle proﬁles to human longevity, we set out to answer
four questions. The ﬁrst question was whether the associa-
tion observed in the Ashkenazi Jewish founder population
could be conﬁrmed in and broadened to an outbred
European population. The second was whether the beneﬁcial
lipoprotein proﬁles marked only familial exceptional lon-
gevity or also extended to sporadic longevity in the general
population. The third question was whether the observed
associations depended on triglyceride levels, a major deter-
minant of lipoprotein particle size [9,10]. And ﬁnally, we
assessed whether beneﬁcial protein proﬁles were also
associated with a better health status.
To answer these questions, we studied lipoprotein particle
proﬁles measured using NMR in two populations. We
investigated familial longevity in long-lived siblings, their
offspring, and the partners of their offspring (Leiden
Longevity Study) [4]. Sporadic longevity reﬂecting the
phenotype in the general population was studied in 90-y-
old participants from a population-based study (the Leiden
85-plus Study) [11].
Methods
Participants
Leiden Longevity Study. For the Leiden Longevity Study
[4], long-lived siblings were recruited together with their
offspring and the partners of their offspring. Families were
eligible for the study if (i) at least two long-lived, full siblings
were alive, where men were considered to be long-lived if
they were 89 y or older and women if they were 91 y or older,
and (ii) the parents of the sibship were from Dutch descent. In
2001, less than 0.5% of the Dutch population fulﬁlled these
sex-speciﬁc age criteria. Ages were veriﬁed using passport,
birth certiﬁcate, or marriage certiﬁcate. The study popula-
tion is enriched for familial inﬂuences on longevity because
offspring of the long-lived siblings, as well as other ﬁrst-
degree relatives, have an on-average 30% lower mortality rate
as compared with their birth cohort [4]. In the long-lived
siblings, overall health status was estimated using question-
naires on (instrumental) activities of daily living (ADL)
[12,13]. In case of cognitive impairment, these data were
obtained from a guardian.
Leiden 85-plus Study. Between September 1997 and
September 1999, all inhabitants of Leiden were asked to
participate in the Leiden 85-plus Study within a week after
they turned 85 y, irrespective of health status [11]. As part of
the follow-up of the study, all participants were visited again
when they reached 90 y. The 90-y-old participants from this
population (90-y-old singletons) were considered sporadic
nonagenarians as opposed to the nonagenarian siblings in the
Leiden Longevity Study selected for their familial longevity
background. During the interview with participants, compe-
tence in ADL was measured with the Groningen Activity
Restriction Scale (GARS) [14]. For participants with severe
cognitive impairment, information was obtained from a
responsible person. Both the Leiden 85-plus Study and the
Leiden Longevity Study were approved by the ethical
committee of the Leiden University Medical Centre, and all
participants signed an informed consent.
Classical Lipids and NMR Analysis of Lipoprotein
Subclasses
A venous blood sample was drawn from the participants.
Classical lipids, including total cholesterol, HDL cholesterol,
andtriglycerides,weremeasuredusingstandardmethods.LDL
cholesterol level (LDL-C) was calculated using the Friedewald
formula (LDL-C ¼ total cholesterol   HDL-C   (triglycerides/
2.2); unit mmol/l) and set to missing if plasma triglyceride
concentration exceeded 4.52 mmol/l. For lipoprotein particle
measurement, serum was available in the Leiden Longevity
Study and citrate plasma in the Leiden 85-plus study. Vacuum
tubes for plasma collection contained citrate in liquid form
leading to dilution and osmotic effects. Therefore, only mean
lipoprotein particle sizes, which are not affected by these
effects, but not particle concentrations could be used for
comparisons across the two study populations. The NMR
lipoprotein subclass proﬁle was determined using a 400-MHz
proton NMR analyzer at LipoScience (http://www.liposcience.
com). In brief, the NMR method uses the characteristic signals
broadcastbylipoproteinsubclassesofdifferentsizeasthebasis
of their quantiﬁcation [15]. Each measurement produces the
signal amplitudes of lipoprotein subclasses that allows one to
estimate the total LDL and HDL particle concentration as well
as their subclasses including large (21.3–23.0 nm) and small
(18.0–21.2 nm) LDL particles. For this estimation, conversion
factors are used to relate these signal amplitudes to particle
concentration or lipid mass concentration units, which were
obtained from NMR and chemical lipid analyses of a set of
puriﬁed subclass standards. Particle concentrations (nmol/l)
were derived for each subclass standard by measuring the total
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and dividing the volume occupied by these lipids by the core
volume per particle calculated from knowledge of the
particle’s diameter. Triglyceride concentrations were calcu-
latedfrom NMR subclass measurements. Average particle sizes
(diameter in nanometres) of LDL and HDL were determined
by weighting the relative mass percentage of each subclass
according to its diameter. Note that due to the relatively small
range in diameters for various LDL and HDL lipoprotein
subclasses and the weighting, limited absolute inter-individual
differences exist in mean particle sizes (resulting in small
standard deviations and standard errors). NMR LDL sizes are
consistent with electron microscopy data and uniformly ;5
nm smaller than those estimated by gradient gel electro-
phoresis due to different referencing.
Statistical Analysis
Mean particle sizes were normally distributed. To obtain
normally distributed variables for particle concentrations, a
square-root transformation was used. Back-transformed data
are presented, and standard errors were calculated using the
delta method. Differences in particle sizes and concentrations
for LDL and HDL particles between long-lived siblings, their
offspring, and the partners of their offspring were assessed
using linear regression. In these analyses, the three groups of
individuals were included as a categorical variable together
with age and sex. To take into account dependencies within
families (i.e., a long-lived sibship with all offspring and their
partners), robust standard errors were used, i.e., the variance
was computed from the between-family variation [16]. p-
Values were also based on these robust standard errors. To
assess the robustness of our ﬁndings, we also performed the
analyses in the subset of complete partner offspring pairs.
Furthermore, interaction with sex was tested.
Mean particle sizes were also compared between 259 90-y-
old singletons and the partners, offspring, and long-lived
siblings using linear regression. Associations were again
adjusted for age and sex, and the within-family correlation
was taken into account when computing standard errors. To
study whether the identiﬁed relationships between particle
phenotypes and longevity depended on triglyceride levels, we
repeated all analyses including triglyceride levels as covariate
in the model. In the analysis of the association with
competence measures in ADL, a measure of overall health
in the very old, the ADL score was used as a continuous
variable. All analyses were performed using STATA SE
version 8 (http://www.stata.com).
Results
To test lipoprotein proﬁles for their association with
longevity, we recruited 1,094 individuals from 165 families
consisting of long-lived siblings (probands; n ¼ 340), their
offspring (n ¼ 511), and partners of their offspring (n ¼ 243;
Figure 1). To assess the relevance of our ﬁndings for sporadic
longevity (longevity not enriched for familial inﬂuences), we
studied the lipoprotein proﬁles in 90-y-old singletons from
the general population (n ¼ 259; Figure 1).
Classical lipid levels as well as the mean size and
concentration of lipoprotein particles were measured in
partners, offspring, and long-lived siblings by NMR. Offspring
had larger (p¼0.020) and fewer (p¼0.011) LDL particles than
their partners (Table 1). These differences were present at all
ages (Figure S1) and more apparent when partners were
compared with long-lived siblings (both p , 10
 3). This
ﬁnding is in agreement with the expectation that factors
related to the familial longevity phenotype are diluted in the
offspring because only one of their parents was selected for
longevity. In contrast, the mean HDL particle size was
virtually identical in offspring and partners and the HDL
particle concentration not signiﬁcantly lower in offspring
than in partners (Table 1). Larger HDL particles and lower
particle concentration were found among long-lived siblings.
For classical HDL-cholesterol and triglyceride levels, no
signiﬁcant difference was observed between partners and
offspring. Offspring did, however, have signiﬁcantly higher
LDL-cholesterol levels than their partners (Table 1). Such
higher LDL-cholesterol levels were not observed among long-
lived siblings.
To assess the robustness of these ﬁndings, we tested for
differences in lipoprotein particle proﬁles within partner–
offspring pairs (236 complete pairs available). The age- and
sex-adjusted LDL particle size was 0.11 nm larger (p ¼ 0.079)
and the LDL particle concentration 109 nmol/l lower (p ¼
0.009) in offspring than in their partners. No differences for
HDL particle phenotypes were observed (p¼0.67 and p¼0.18
for particle size and concentration, respectively).
A closer inspection of the association found for LDL
particles showed that it could be attributed to a 13% lower
small LDL particle concentration (p ¼ 0.012) in offspring as
compared with partners but not a higher concentration of
large LDL particles (p ¼ 0.19). Again, the contrast was even
greater in long-lived siblings who had on average a 48% lower
concentration of small LDL particles than partners of their
offspring (p , 10
 4; Figure 2). Subclassiﬁcation of the total
HDL particle concentration according to size did not reveal
consistent signiﬁcant associations (unpublished data).
Next, we investigated men and women separately. Among
men, the association between familial longevity and total LDL
particle concentration was highly signiﬁcant. Offspring had a
12% (p¼0.001) and long-lived siblings a 30% (p¼10
 4) lower
particle concentration than partners (Table 2). Although the
same trend was observed among women, this was signiﬁcantly
attenuated (pinteraction ¼ 0.043). As a consequence, the 15%
higher LDL particle concentration in men than women
among partners was inverted to 5% lower concentration in
Figure 1. Study Design
Long-lived families were recruited if they included a long-lived sibling
pair with males aged 89 y or older and women aged 91 y or older.
doi:10.1371/journal.pmed.0030495.g001
PLoS Medicine | www.plosmedicine.org December 2006 | Volume 3 | Issue 12 | e495 2319
Lipoprotein Particles and Longevitymen than women among partners among long-lived siblings.
Separate analysis of men and women further suggested that, if
present, the association of total HDL particle concentration
with a familial propensity for longevity was mainly found
among women (p¼0.037 for the comparison of partners with
offspring).
To test whether the relevance of lipoprotein particle
subclasses extended to the general population, we measured
LDL and HDL particle proﬁles in 259 90-y-old singletons.
Since a different sample type was available (now plasma
instead of serum), only mean particle sizes could be used for
comparison with long-lived siblings. The mean LDL particle
size in 90-y-old singletons was similar to that in long-lived
siblings (21.58 nm and 21.61 nm, respectively) and also
signiﬁcantly larger than in partners of offspring (p ¼ 0.001;
Figure 3). For HDL particles, the same observation was made:
mean sizes were comparable in 90-y-old singletons and long-
lived siblings (9.45 nm and 9.42 nm, respectively), and the
mean HDL particle size was signiﬁcantly larger in 90-y-old
singletons than partners (p , 10
 3; Figure 3).
In order to investigate whether lipoprotein particle
subclasses mark not only longevity but also health status, we
assessed the overall health status in long-lived siblings and 90-
y-old singletons using questionnaires about daily activities. A
lower concentration of particularly small LDL particles was
associated with better health in both long-lived siblings (p ¼
0.003) and the 90-y-old singletons (p ¼ 0.007). This result is
consistent with the ﬁndings on longevity. For total HDL
particle concentration, however, these analyses revealed an
opposite effect. Whereas long-lived siblings and 90-y-old
singletons had non-signiﬁcantly fewer HDL particles than
younger controls, within these elderly groups fewer HDL
particles were associated with poorer health (both p , 10
 4).
Part of the variation in particle size and concentration may
be attributable to differences in triglyceride levels, which can
be measured routinely [9,10]. The differences found for LDL
particle phenotypes between partners and offspring, how-
Table 1. Characteristics, Classical Lipids, and LDL and HDL Particle Size and Concentration in Individuals with an Increasing Familial
Propensity for Longevity
Category Variable Partners (Controls) Offspring Long-Lived Siblings p-Value
Offspring
versus
Partners
Siblings
versus
Partners
Number of
individuals
243 511 340
Number of
families
108 147 164
Men (%) 110 (45%) 226 (44%) 116 (34%)
Mean age in
years (range)
59.6 (35.8–79.0) 60.6 (39.0–80.5) 94.1 (89.3–103.9)
Classical
lipids
DL-C in mmol/l (SE) 3.23 (0.06) 3.49 (0.05) 2.86 (0.05) ,10
 3 0.064
HDL-C in mmol/l (SE) 1.45 (0.03) 1.41 (0.02) 1.49 (0.03) 0.239 0.458
Triglycerides in mmol/l (SE) 1.73 (0.03) 1.65 (0.03) 1.47 (0.02) 0.135 ,10
 3
LDL
particles
Mean size in nm (SE) 21.10 (0.06) 21.25 (0.05) 21.61 (0.05) 0.020 ,10
 3
Concentration in nmol/l (SE) 1,561.23 (30.60) 1,469.99 (27.47) 1,220.04 (25.69) 0.011 ,10
 6
HDL particles Mean size in nm (SE) 8.98 (0.03) 8.99 (0.03) 9.42 (0.03) 0.72 ,10
 3
Concentration in lmol/l (SE) 36.15 (0.57) 35.05 (0.36) 29.32 (0.41) 0.093 ,10
 5
p-Values were adjusted for family relationship using robust standard errors to take into account the covariance between family members and for sex and age.
doi:10.1371/journal.pmed.0030495.t001
Figure 2. Concentration of Large and Small LDL Particles in Serum of Offspring and Long-Lived Siblings Compared with Partners
(A) Large LDL particles; (B) small LDL particles.
* p   0.02 for comparison versus partners (controls); ** p   10
 3 for comparison versus partners (controls).
doi:10.1371/journal.pmed.0030495.g002
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triglyceride levels (p ¼ 0.028, p ¼ 0.014, and p ¼ 0.012 for
size, total, and small particle concentration, respectively),
indicating the added value of explicitly measuring particle
size and concentration. The only signiﬁcant difference
between partners and offspring we observed for a HDL
particle phenotype, namely among women for total HDL
particle concentration, however, did not remain statistically
signiﬁcant after adjusting for triglyceride levels (p¼0.11). The
differences for LDL particle phenotypes between partners
and offspring also persisted after adjustment for triglyceride
levels as well as classical LDL and HDL cholesterol levels (p ¼
0.038, p , 0.01, and p , 0.01 for size, total, and small particle
concentration, respectively).
Discussion
We employed a study design tailored to identify genetic
and biochemical markers for human longevity and healthy
ageing. We studied Dutch families consisting of long-lived
siblings, their offspring, and partners of their offspring, who
served as controls. Human longevity clustered in these
families: parents, siblings, and, crucially, offspring of the
recruited long-lived siblings have an on average 30% lower
mortality rate than their birth cohort [4]. In the current
study, we investigated whether lipoprotein particle proﬁles in
blood are associated with human longevity. We found that the
offspring of long-lived siblings had signiﬁcantly larger and
fewer LDL particles than their partners who may be
considered matched by age and household environment.
The contrast in both LDL particle phenotypes was even more
prominent when partners were compared with long-lived
siblings. These two associations were traced back to a single
phenotype being a lower concentration of small LDL
particles. Our study constitutes the ﬁrst independent
conﬁrmation of ﬁndings previously described in long-lived
families from the Ashkenazi Jewish founder population,
namely, a signiﬁcantly larger mean LDL particle size among
offspring of long-lived individuals than their partners (0.2 nm
larger for men and 0.5 nm for women, respectively) [8].
Moreover, it extends the association of LDL particle
phenotypes with familial longevity to an outbred, European
population. Also, we now identiﬁed small LDL particle
concentration as the main culprit and showed that the
inﬂuence of LDL particle phenotypes is independent of
triglyceride levels, which are main determinants particularly
of the LDL size [9,10] that was studied in the original report.
Of note, we found signiﬁcantly higher classical LDL-choles-
terol levels among offspring than partners, but we did not
observe similarly increased LDL-cholesterol levels among
long-lived siblings. Although we currently do not have an
explanation for this ﬁnding, it reinforces the notion that
familial longevity is not associated with low LDL-cholesterol
levels [8]. Our study thus underscores the added value
of detailed measurements on lipid metabolism, such as
lipoprotein particle concentrations, instead of measuring
classical lipid levels only.
The relevance of LDL size and subclasses, however, may not
be conﬁned to familial longevity. The 90-y-old singletons
from a population-based survey equally showed a larger mean
LDL particle size. The great similarity in familial and
sporadic human longevity suggests that both genetic and
environmental factors may induce the beneﬁcial LDL particle
phenotype that marks the propensity for human longevity.
Also, in both long-lived siblings and 90-y-old singletons a
lower concentration of small LDL particles was associated
with better overall health. Taken together, our data indicate
that an under-representation of small LDL particles marks
longevity and health in the general population and is
associated with the propensity for longevity already in middle
age. Future studies in cohorts of elderly individuals prospec-
tively followed for a long period are warranted to explore the
associations of small LDL particles in depth.
Longevity in long-lived Ashkenazi Jewish families was also
marked by a larger mean HDL particle size [8]; however, we
could not replicate this result. The single signiﬁcant differ-
ence between partners and offspring we observed was for
total HDL particle concentration among women, but
correction for triglyceride levels abolished the signiﬁcance
of this association. Despite the absence of an association in
this age-controlled comparison, larger and fewer HDL
particles were found in the long-lived siblings as compared
with their offspring and controls. Although this may be in line
with a beneﬁcial association of HDL particle phenotypes in
old age, we found opposite associations of total HDL particle
concentration with an indicator of overall health status in
both nonagenarian groups. In Ashkenazi Jewish families,
homozygosity of the I405V variant in the CETP gene was
associated with a larger mean HDL size and its frequency
signiﬁcantly increased from controls, offspring to centenar-
ians. In our study, however, this genotype was not associated
with a larger mean HDL size nor did we and others [17] ﬁnd a
Table 2. Total LDL and HDL Particle Concentration Separately for Men and Women with an Increasing Familial Propensity for
Longevity
Particle
Concentration
Sex Partners (Controls) Offspring Long-Lived
Siblings
p-Value
Offspring versus
Partners
Siblings versus
Partners
Total LDL in nmol/l (SE) Men 1,679.57 (48.52) 1,483.71 (32.92) 1,183.03 (39.14) 0.001 10
 4
Women 1,466.62 (43.43) 1,459.16 (34.91) 1,239.43 (30.88) 0.62 0.005
Total HDL in lmol/l (SE) Men 34.22 (0.75) 33.60 (0.57) 28.14 (0.65) 0.38 0.028
Women 37.79 (0.70) 36.22 (0.45) 29.94 (0.46) 0.037 ,10
 5
p-Values were adjusted for family relationship using robust standard errors to take into account the covariance between family members and for sex and age.
doi:10.1371/journal.pmed.0030495.t002
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data are compatible with the interpretation that HDL
particle phenotypes are a consequence of unknown factors
associated with old age. The disparate outcomes between the
studies may be due to differences in inclusion criteria,
inclusion of confounders, and populations studied.
On the basis of the current and previous study [8], it may be
speculated that small LDL particles are a candidate bio-
marker for the rate of biological ageing. Offspring of long-
lived siblings with a familial propensity for human longevity
express this marker already around the age of 60 y, long
before the longevity phenotype becomes evident. It is,
however, unclear whether small LDL particles play a causal
role. Small LDL particles have been suggested to promote
atherosclerosis because they are susceptible to oxidation and
may easily accumulate in the arterial wall [18]. This
hypothesis is supported by the ﬁnding that the concentration
of small LDL particles predict the risk of cardiovascular
disease [9], although large LDL particles have also been
associated with coronary heart disease [18]. An intriguing
aspect of our study is that long-lived men and women had a
much more comparable LDL particle concentration than
male and female controls with a mean age of 60 y. This
ﬁnding might be associated with the convergence of the sex-
speciﬁc cardiovascular mortality rates in old age. An
alternative explanation for our ﬁnding is that small LDL
particles are not causally involved but mark an adverse
metabolic state that contributes to the future risk of disease
or monitor early features of disease. The occurrence of
smaller mean LDL size among type II diabetes patients has
been well established since the early 1990s [19], and, recently,
a higher concentration of small LDL particles as measured
with NMR was shown to be strongly associated with lower
insulin sensitivity [10]. The relationship with metabolic
disease might reﬂect that small LDL particles mark mecha-
nisms involved in the rate of biological ageing. Studies into
the determinants of maximum lifespan in animal models have
revealed pathways that may be important for human
longevity. They indicated, for example, that genes from the
insulin pathway regulate lifespan across species, simultane-
ously affecting stress response, fertility, and basic metabolic
properties [20]. Lipid transport and storage may likewise
constitute a central process in ageing and longevity [21].
In conclusion, we found evidence that a low concentration
of small LDL particles marks human longevity already in
middle age. Our study extends the ﬁnding that LDL particles
are associated with human longevity in a genetically isolated
population to an outbred European Caucasian population. It
further indicated that this association is present not only
among individuals with exceptional familial longevity but also
in the population at large. Since long-lived individuals escape
death from diverse common diseases, including cardiovascu-
lar diseases and cancer [6], it will be important to establish
whether our ﬁnding reﬂects resistance to a speciﬁc disease or
indicates longevity-associated pathways that have a broader
effect on ageing, for example by regulating metabolism, stress
resistance, or immune function.
Supporting Information
Figure S1. LDL and HDL Particle Concentrations in Partners,
Offspring, and Long-Lived Siblings according to Age Strata
(A) LDL; (B) HDL. Error bars are standard errors. LDL particle
concentration was positively associated with age (p ¼ 0.028); HDL
particle concentration was not (p ¼ 0.74).
Found at doi:10.1371/journal.pmed.0030495.sg001 (5.1 MB TIF).
Accession Numbers
The Online Mendelian Inheritance in Man (OMIM; http://www.ncbi.
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and CETP (118470).
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Editors’ Summary
Background. It is not clear why some people go on to live longer than
others do. Some studies have shown that close relatives of long-lived
people are themselves more likely to live for a long time; these findings
suggest that there is probably a genetic basis for long life. However, the
actual mechanisms involved have not yet been worked out. Some genes
coding for proteins involved in fat metabolism, such as APOE, APOB, and
CETP, have been associated with long life, suggesting a link between the
way fat gets metabolized and the aging process. One study that
supports this idea found that the children of 100-year-old people had
larger lipoprotein particles (assemblies of proteins and fats that carry
cholesterol and triglycerides in the blood) than similarly aged control
individuals. However, studies such as this are very prone to ‘‘false
positive’’ findings and therefore need to be backed up by confirmatory
evidence. In addition, the previous study was performed in a very specific
population (Ashkenazi Jewish people), and it is important to find out
whether the findings are also true in other populations.
Why Was This Study Done? The research group carrying out this study
wanted to address several distinct questions to do with the genetics of
aging. Firstly, they wanted to see if they could confirm previous findings
associating large lipoprotein particles with longer life, but looking at
people who were more representative of the general European
population and not from a genetically isolated population. Secondly,
they wanted to see whether this association applied to only long-lived
people whose family members were also long-lived, or to long-lived
people in general. Finally, they wanted to find out if the large lipoprotein
particles were associated with better health.
What Did the Researchers Do and Find? In the study, the researchers
looked at long-lived people from across The Netherlands whose relatives
were also long-lived. For this, they recruited 340 men aged over 89 and
women aged over 91 into the study, all of whom had at least one
similarly long-lived sister or brother. Their children (511 individuals), and
the partners of their children (243 people), were also recruited into the
study, with the partners acting as ‘‘controls.’’ The researchers also
studied 259 people who had just turned 90 years old; these people were
included to see whether particular characteristics of lipoproteins existed
in long-lived people whose longevity did not run in families. All the
participants gave blood samples, and the researchers then measured the
size and amount of different lipoprotein particles in these samples. Two
types of lipoprotein particles were looked at: low-density lipoprotein
(LDL, often termed ‘‘bad cholesterol’’) and high-density lipoprotein (HDL,
sometimes called ‘‘good cholesterol’’). The researchers found that the
children from the long-lived people had larger and fewer LDL particles
than their partners (the ‘‘control’’ individuals) just like their long-lived
parents. Thus even though the children were not long-lived themselves,
LDL particles marked the fact that they have a higher chance of
becoming long-lived in the future. Similar changes in LDL particles were
found for long-lived people whose relatives were not also long-lived.
Interestingly, simply the level of cholesterol—the classical risk factor for
cardiovascular disease—did not appear to play a role. Thus it seems that
it is not the amount of cholesterol that is important in longevity but how
it is packaged. Better health status was also associated with a lower
proportion of small LDL particles in the blood, supporting these findings.
No characteristics of the HDL particles seemed to be associated with
longevity.
What Do These Findings Mean? These findings confirm those from a
previous study in Ashkenazi Jewish people that suggested that the size
of LDL particles in the blood was associated with long life. The nature of
this association is not clear; some studies indicated that small LDL
particles increase the risk of cardiovascular disease but small LDL
particles may also be harmless themselves and reflect the efficiency of
other processes causally related to aging.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0030495.
  Wikipedia chapter on senescence (biology of aging) (note that
Wikipedia is a free Internet encyclopedia that anyone can edit)
  US National Institute on Aging provides information on healthy aging,
details of publicly funded research into aging, and other resources for
the public
  Help the Aged information on research into aging
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